Cargando…
Cell-free DNA as a Promising Diagnostic Biomarker in Prostate Cancer: A Systematic Review and Meta-Analysis
OBJECTIVE: The detection of cell-free DNA (cfDNA) as a part of “liquid biopsy” of prostate cancer (PCa) has been widely explored. However, its diagnostic value for PCa remains controversial. Based on the data from the latest literature published in the past decade, the present review was conducted t...
Autores principales: | Zhang, Cong, Chao, Fan, Wang, Shiyu, Han, Dunsheng, Chen, Gang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9166979/ https://www.ncbi.nlm.nih.gov/pubmed/35669243 http://dx.doi.org/10.1155/2022/1505087 |
Ejemplares similares
-
The Emerging Role of Circular RNAs in Prostate Cancer: A Systematic Review
por: Chao, Fan, et al.
Publicado: (2021) -
Circular RNA circSMARCA5 is a prognostic biomarker in patients with malignant tumor: a meta-analysis
por: Chao, Fan, et al.
Publicado: (2021) -
HNRNPC Promotes Proliferation, Metastasis and Predicts Prognosis in Prostate Cancer
por: Wang, Shiyu, et al.
Publicado: (2021) -
Alpha-L-Fucosidase Has Diagnostic Value in Prostate Cancer With “Gray-Zone PSA” and Inhibits Cancer Progression via Regulating Glycosylation
por: Zhang, Cong, et al.
Publicado: (2021) -
Deep Learning-Based Multi-Omics Integration Robustly Predicts Relapse in Prostate Cancer
por: Wei, Ziwei, et al.
Publicado: (2022)